Search

Your search keyword '"Faust U."' showing total 50 results

Search Constraints

Start Over You searched for: Author "Faust U." Remove constraint Author: "Faust U." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
50 results on '"Faust U."'

Search Results

1. ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways:lessons from breast cancer patients

3. Beyond BRCA1 and BRCA2 – evaluation of 123 carriers of pathogenic variants in other HBOC associated genes

4. Genomsequenzierung in der FBREK-Diagnostik

5. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

6. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

9. Klinisch-pathologische Charakterisierung von 1078 Ratsuchenden mit pathogener CHEK2 Mutation aus dem Deutschen Konsortium Familiärer Brust- und Eierstockkrebs (DK-FBREK)

10. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

11. Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness.

12. Clinical-pathological Characterization of 1078 Advice Seekers with pathogenic CHEK2 Mutation from the German Consortium of Familial Breast and Ovarian Cancer (DK-FBREK)

13. Clinical and molecular characterization of 1253 carriers of a deleterious CHEK2 mutation from the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC)

14. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness

16. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer.

17. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

18. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

19. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

20. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

21. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

22. Prädiktive Testung bei Familienangehörigen von BRCA1, BRCA2 und CHEK2 Mutationsträgerinnen am Universitätsbrustzentrum Tübingen – eine klinische retrospektive unizentrische Kohortenstudie

23. Konsensusempfehlung des Deutschen Konsortiums Familiärer Brust- und Eierstockkrebs zur Integration von Daten aus Multigenanalysen in das klinische Versorgungsprogramm

24. Truncating variants in DNA-repair genes and their effect on AAO of hereditary breast cancer

25. Consensus recommendation of the German Consortium for Hereditary Breast and Ovarian Cancer (GC-HBOC) on the transfer of multigene analysis data into the clinical care program

28. Häufigkeit der „erblichen Belastung für Brust- und Eierstockkrebs“ bei Patientinnen mit Mammakarzinom am Brustzentrum der Universitätsfrauenklinik Tübingen

31. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.

32. Genome sequencing identifies complex structural MLH1 variant in unsolved Lynch syndrome.

33. ABRAXAS1 orchestrates BRCA1 activities to counter genome destabilizing repair pathways-lessons from breast cancer patients.

34. Germline findings in patients with advanced malignancies screened with paired blood-tumour testing for personalised treatment approaches.

35. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

36. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants.

37. Detection of mobile elements insertions for routine clinical diagnostics in targeted sequencing data.

38. Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.

39. Criteria of the German Consortium for Hereditary Breast and Ovarian Cancer for the Classification of Germline Sequence Variants in Risk Genes for Hereditary Breast and Ovarian Cancer.

40. Efficacy of MMP-inhibiting wound dressings in the treatment of chronic wounds: a systematic review.

41. Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

42. Single Molecule Molecular Inversion Probes for High Throughput Germline Screenings in Dystonia.

43. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.

44. Investigating the effects of additional truncating variants in DNA-repair genes on breast cancer risk in BRCA1-positive women.

45. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.

46. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer.

47. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

48. Prevalence of BRCA1/2 germline mutations in 21 401 families with breast and ovarian cancer.

49. Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms.

50. HBOC multi-gene panel testing: comparison of two sequencing centers.

Catalog

Books, media, physical & digital resources